MedTrace Logo

Comparative Effectiveness of Adaptive Treatment Strategies for Schizophrenia

NCT02775864 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 81921

Last updated 2024-05-01

Study results available
· View outcomes & findings →

Summary

The study is a retrospective cohort study of adults with schizophrenia that will compare outcomes of new users of alternative psychotropic medication strategies using 10 years of Medicaid data. The primary comparative effectiveness analyses will focus on subgroups of patients with schizophrenia facing common clinical situations.

Conditions

Interventions

DRUG

Antipsychotic

New initiation of any antipsychotic medication

DRUG

Antidepressant

New initiation of any antidepressant medications

DRUG

Benzodiazepine

New initiation of any benzodiazepine

DRUG

Mood stabilizer

New initiation of lithium or any mood stabilizing anti-epileptic drug

Sponsors & Collaborators

  • Rutgers University

    collaborator OTHER

  • Patient-Centered Outcomes Research Institute

    collaborator OTHER

  • New York State Psychiatric Institute

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2018-04-30
Completion
2018-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02775864 on ClinicalTrials.gov